Former Senior Vice President and Chief Development Officer (6) · PALVELLA THERAPEUTICS, INC. (PVLA)

Shane Olwill

FY2023 is the first fiscal year CompBrief holds for Shane Olwill as a named executive officer of PALVELLA THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$705,445

Salary $328,614Stock awards $0Bonus $127,702

4th of 6 named executive officers at Palvella Therapeutics by FY2023 total.

6 named officers on file for PALVELLA THERAPEUTICS, FY2023

Shane Olwill’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PALVELLA THERAPEUTICS’s whole pay program stands against its peers

  • PALVELLA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PVLA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed November 6, 2024 (DEF 14A).

Free

Get Shane Olwill’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Shane Olwill compensation by year

PALVELLA THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as PALVELLA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$328,614
Bonus$127,702
Stock awards$0
Option awards$241,536
Non-equity incentive$0
Pension and deferred compensation$0
All other$7,593
Total$705,445

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALVELLA THERAPEUTICS, INC. DEF 14A filed November 6, 2024, accession 0001437749-24-033669, and prior-year filings. Open the filing on EDGAR.

How this page was built: the PALVELLA THERAPEUTICS, INC. filed document, accession 0001437749-24-033669. Every figure is read from that document and cited to the page and table it appears in. Filed November 6, 2024.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option3,114—$111.20
Option70—$252.00
Option586—$200.00
Option1,517—$242.40

Per the Outstanding Equity Awards at Fiscal Year-End table in PALVELLA THERAPEUTICS, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

PALVELLA THERAPEUTICS’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Stephen YoderFormer Chief Executive Officer$1,358,952
Kathleen GoinChief Operating Officer$1,345,807
Thomas BuresSenior Vice President and Chief Financial Officer$729,037
Shane Olwill · this pageFormer Senior Vice President and Chief Development Officer (6)$705,445
Jeffrey MartiniChief Scientific Officer$614,979
Wesley KaupinenPresident and Chief Executive Officer$585,963

The full PALVELLA THERAPEUTICS compensation record

free company brief

This page is one person within PALVELLA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALVELLA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Shane Olwill's compensation dossier · One-time report. No refunds.